Overview

Detailed Summary

NOCIL Limited is India’s largest manufacturer and supplier of rubber chemicals, producing accelerators, antioxidants, anti‑degradants and other specialty additives from Navi Mumbai and Dahej plants for tyre and industrial rubber customers across 40+ countries; the company is part of the Arvind Mafatlal Group and emphasizes technical services, approvals and sustainable product development.
In Q3 FY26 NOCIL reported consolidated revenue of Rs.316 crore with volumes showing an upward trajectory (index 140 versus Q1FY20 base), while nine‑month revenue declined 8% year‑on‑year to Rs.973 crore; operating EBITDA improved sequentially to Rs.27 crore (8.5% margin) but nine‑month PAT contracted steeply, reflecting pricing pressure, inventory swings and taxation effects.
NOCIL is executing a substantive Rs.250 crore brownfield capex at Dahej coupled with TDQ antioxidant capacity augmentation and trial runs slated for H1 CY2026; management expects earlier completion and believes the investment will boost exports, support China+1 sourcing shifts and underpin medium‑term market share gains across Asia, Europe and the U.S.
Competitive headwinds include persistent dumping and aggressive imports (China, Korea) plus U.S. tariff‑related demand disruption; NOCIL has filed multiple antidumping petitions, investigations are underway, and favourable trade‑remedy outcomes could materially restore pricing power and margin profile for the company.
Sustainability and technology are strategic priorities: NOCIL’s recognized R&D centre, pilot plant and Green Chemistry focus support a pipeline of new‑generation rubber chemicals expected to contribute roughly 10–12% of volumes over the medium term, while Responsible Care recertification and Ecovadis Silver rating bolster ESG credentials.

Sector: Chemicals & Petrochemicals
Industry: Specialty Chemicals
Market Cap: 2,605 Cr
Volatility: Low Risk
P/E Ratio: 46.8
Industry P/E: 43.0
PEG Ratio: 2.4
P/B Ratio: 1.5
52W High: 211.00
52W Low: 125.35

Sales CAGR

1Y: -3.60%
3Y: -3.94%
5Y: 10.48%
10Y: 6.52%

Profit CAGR

1Y: -22.66%
3Y: -15.12%
5Y: -3.86%
10Y: 3.68%

ROE

TTM: 3.14%
3Y: 7.68%
5Y: 8.39%
10Y: 10.47%

ROCE

TTM: 4.35%
3Y: 9.22%
5Y: 10.12%
10Y: 13.20%

Technicals

‌

Forecasts

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Peers

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
YASHO		2460.15	2,966 Cr	117.43	6.68	0.02	5.69	8.71	2.19
ROSSARI		526.15	2,919 Cr	19.56	2.19	0.09	11.19	13.06	6.52
JUBLCPL		1826.00	2,789 Cr	21.82	6.06	0.00	27.80	34.27	13.67
TATVA		1193.90	2,770 Cr	65.87	3.54	0.00	5.38	6.63	4.19
NOCIL		161.40	2,696 Cr	48.46	1.52	0.93	3.14	4.35	2.64
DDEVPLSTIK		251.40	2,599 Cr	12.88	2.57	0.70	19.92	28.27	13.98
CAMLINFINE		135.00	2,593 Cr	93.86	2.49	0.00	1.18	3.77	1.01
Median: 7 Co.	—	526.15	2,770 Cr	48.46	2.57	0.02	5.69	8.71	4.19

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	341	357	372	363	318	340	336	321	316	330
Expenses	292	312	331	325	294	305	306	298	289	309
Operating Profit	49	45	41	38	24	34	31	22	27	21
OPM %	14.34	12.52	11.03	10.42	7.55	10.07	9.10	6.96	8.49	6.37
Other Income	5.83	25	9.34	8.41	9.08	5.62	6.60	10	0.81	14
Interest	0.50	0.42	0.46	0.53	0.45	0.36	0.37	0.35	0.34	0.33
Depreciation	13	13	13	13	14	13	14	14	14	14
Profit Before Tax	41	56	37	32	19	26	23	19	13	21
Tax %	26.27	25.29	26.39	-30.31	32.43	19.95	25.41	34.56	31.02	18.85
Net Profit	30	42	27	42	13	21	17	12	9.25	17
EPS in Rs	1.79	2.47	1.62	2.53	0.76	1.25	1.03	0.73	0.55	1.01

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	818	989	1,043	846	925	1,571	1,617	1,445	1,393	1,357
Expenses	583	702	750	668	794	1,285	1,364	1,250	1,255	1,230
Operating Profit	235	287	293	178	131	286	253	195	137	127
OPM %	28.75	29.01	28.07	21.06	14.15	18.21	15.63	13.50	9.87	9.33
Other Income	9.52	15	9.96	9.17	15	3.88	6.24	39	32	30
Interest	2.22	1.22	0.63	1.32	0.97	1.09	1.20	1.62	1.79	1.71
Depreciation	20	24	24	34	37	48	56	53	54	54
Profit Before Tax	147	255	278	152	107	241	202	180	114	101
Tax %	33.84	33.28	33.44	14.22	17.47	26.81	26.20	26.11	9.88	7.41
Net Profit	97	170	185	131	88	176	149	133	103	93
EPS in Rs	—	—	11.01	7.82	5.29	10.52	8.91	7.93	6.15	3.32
Dividend Payout %	30.46	24.46	22.46	31.69	37.59	28.44	33.63	37.74	32.52	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	161	164	164	165	166	166	167	167	167	167
Reserves	309	750	882	998	1,020	1,119	1,279	1,385	1,532	1,595
Borrowings	16	5.00	0.00	0.00	6.87	5.61	5.52	9.79	13	10
Other Liabilities	196	243	284	279	250	324	380	295	304	284
Total Liabilities	682	1,161	1,331	1,442	1,442	1,615	1,831	1,857	2,015	2,057
Fixed Assets	307	542	527	657	797	917	909	887	869	855
CWIP	6.08	4.47	42	131	156	14	8.37	8.57	16	60
Investments	22	177	282	130	55	69	54	219	400	367
Other Assets	347	438	480	524	434	614	859	742	730	776
Total Assets	682	1,161	1,331	1,442	1,442	1,615	1,831	1,857	2,015	2,057

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	170	142	102	164	179	94	-30	282	201	26
Cash from Investing Activity	-12	-11	-141	-101	-106	-58	31	-217	-77	-37
Cash from Financing Activity	-151	-31	-43	-50	-101	0.27	-34	-54	-55	-50
Net Cash Flow	7.33	101	-82	13	-28	35	-33	11	68	-62

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	33.84%	33.84%	33.84%	33.84%	33.84%	33.79%	33.78%	33.76%	33.76%	33.76%	33.76%	33.76%
FIIs	5.44%	6.36%	6.98%	7.78%	7.77%	7.91%	7.81%	8.15%	6.65%	5.15%	4.47%	4.55%
DIIs	4.70%	3.62%	2.85%	3.52%	4.46%	6.15%	5.93%	5.32%	5.19%	6.57%	6.49%	7.91%
Public	56.02%	56.18%	56.33%	54.86%	53.94%	52.15%	52.49%	52.76%	54.40%	54.52%	55.27%	53.78%
Total Shareholders	1,79,495	1,81,190	1,76,347	1,71,496	1,67,157	1,66,627	1,63,899	1,61,825	1,65,648	1,64,817	1,62,167	1,65,835

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY26

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Available on Pro Plan